WO2012166554A3 - Extracellular matrix material conduits and methods of making and using same - Google Patents

Extracellular matrix material conduits and methods of making and using same Download PDF

Info

Publication number
WO2012166554A3
WO2012166554A3 PCT/US2012/039450 US2012039450W WO2012166554A3 WO 2012166554 A3 WO2012166554 A3 WO 2012166554A3 US 2012039450 W US2012039450 W US 2012039450W WO 2012166554 A3 WO2012166554 A3 WO 2012166554A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
extracellular matrix
making
same
matrix material
Prior art date
Application number
PCT/US2012/039450
Other languages
French (fr)
Other versions
WO2012166554A2 (en
WO2012166554A8 (en
Inventor
Robert G. Matheny
Original Assignee
Cormatrix Cardiovascular, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cormatrix Cardiovascular, Inc. filed Critical Cormatrix Cardiovascular, Inc.
Priority to SG2013083167A priority Critical patent/SG194878A1/en
Priority to KR1020137031538A priority patent/KR20140145954A/en
Priority to JP2014512122A priority patent/JP2014519379A/en
Priority to CA2835859A priority patent/CA2835859A1/en
Priority to BR112013030482A priority patent/BR112013030482A2/en
Priority to EP12793466.9A priority patent/EP2714068B1/en
Priority to AU2012262554A priority patent/AU2012262554B2/en
Publication of WO2012166554A2 publication Critical patent/WO2012166554A2/en
Priority to IL229287A priority patent/IL229287B/en
Publication of WO2012166554A8 publication Critical patent/WO2012166554A8/en
Publication of WO2012166554A3 publication Critical patent/WO2012166554A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2415—Manufacturing methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22—Valves or arrangement of valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0094—Gaseous substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Abstract

Extracellular matrix (ECM) material conduits are disclosed. Methods for regenerating atrioventricular valves to replace defective atrioventricular valves within a heart of a subject using the ECM material conduits are also disclosed. Methods of sterilizing and decellularizing an ECM material are also disclosed.
PCT/US2012/039450 2011-05-27 2012-05-24 Extracellular matrix material conduits and methods of making and using same WO2012166554A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SG2013083167A SG194878A1 (en) 2011-05-27 2012-05-24 Extracellular matrix material conduits and methods of making and using same
KR1020137031538A KR20140145954A (en) 2011-05-27 2012-05-24 Extracellular matrix material conduits and methods of making and using same
JP2014512122A JP2014519379A (en) 2011-05-27 2012-05-24 Extracellular matrix material conduit and methods for making and using the same
CA2835859A CA2835859A1 (en) 2011-05-27 2012-05-24 Extracellular matrix material conduits and methods of making and using same
BR112013030482A BR112013030482A2 (en) 2011-05-27 2012-05-24 method of regeneration of an atrioventricular valve and duct of extracellular matrix material
EP12793466.9A EP2714068B1 (en) 2011-05-27 2012-05-24 Extracellular matrix material conduits and methods of making and using same
AU2012262554A AU2012262554B2 (en) 2011-05-27 2012-05-24 Extracellular matrix material conduits and methods of making and using same
IL229287A IL229287B (en) 2011-05-27 2013-11-06 Extracellular matrix material conduits and methods of making and using same

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201161490693P 2011-05-27 2011-05-27
US201161490873P 2011-05-27 2011-05-27
US61/490,873 2011-05-27
US61/490,693 2011-05-27
US201161491723P 2011-05-31 2011-05-31
US61/491,723 2011-05-31
US201261650911P 2012-05-23 2012-05-23
US61/650,911 2012-05-23

Publications (3)

Publication Number Publication Date
WO2012166554A2 WO2012166554A2 (en) 2012-12-06
WO2012166554A8 WO2012166554A8 (en) 2014-01-23
WO2012166554A3 true WO2012166554A3 (en) 2014-05-08

Family

ID=47260207

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/039450 WO2012166554A2 (en) 2011-05-27 2012-05-24 Extracellular matrix material conduits and methods of making and using same

Country Status (8)

Country Link
JP (2) JP2014519379A (en)
KR (1) KR20140145954A (en)
AU (1) AU2012262554B2 (en)
BR (1) BR112013030482A2 (en)
CA (1) CA2835859A1 (en)
IL (1) IL229287B (en)
SG (1) SG194878A1 (en)
WO (1) WO2012166554A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845719B2 (en) 2011-05-27 2014-09-30 Cormatrix Cardiovascular, Inc Extracellular matrix material conduits and methods of making and using same

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016512989A (en) * 2013-03-01 2016-05-12 コーマトリックス カーディオバスキュラー， インコーポレイテッドＣｏｒＭａｔｒｉｘ Ｃａｒｄｉｏｖａｓｃｕｌａｒ， Ｉｎｃ． Two-piece artificial valve
WO2019226803A1 (en) 2018-05-22 2019-11-28 Boston Scientific Scimed, Inc. Percutaneous papillary muscle relocation

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126686A (en) * 1996-12-10 2000-10-03 Purdue Research Foundation Artificial vascular valves
US6719788B2 (en) * 1993-11-01 2004-04-13 3F Therapeutics, Inc. Replacement atrioventricular heart valve
US6991649B2 (en) * 2003-08-29 2006-01-31 Hans-Hinrich Sievers Artificial heart valve
US7087034B2 (en) * 2002-09-19 2006-08-08 Mcpherson William E Vascular shunt with audio flow indication
US7331993B2 (en) * 2002-05-03 2008-02-19 The General Hospital Corporation Involuted endovascular valve and method of construction
US20090157177A1 (en) * 2007-12-18 2009-06-18 Matheny Robert G Sewing Ring for a Prosthetic Tissue Valve
US7887576B2 (en) * 2002-08-20 2011-02-15 Cook Incorporated Endoluminal device with extracellular matrix material and methods

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4790844A (en) * 1987-01-30 1988-12-13 Yoel Ovil Replacement of cardiac valves in heart surgery
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
AU662342B2 (en) * 1991-05-16 1995-08-31 3F Therapeutics, Inc. Cardiac valve
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5275826A (en) 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5480424A (en) 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US6933326B1 (en) 1998-06-19 2005-08-23 Lifecell Coporation Particulate acellular tissue matrix
US6579538B1 (en) 1999-12-22 2003-06-17 Acell, Inc. Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof
US7033611B2 (en) 2001-02-23 2006-04-25 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
CO5500017A1 (en) * 2002-09-23 2005-03-31 3F Therapeutics Inc MITRAL PROTESTIC VALVE
US7108832B2 (en) 2003-06-23 2006-09-19 Novasterilis Inc. Sterialization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant
JP2007105081A (en) * 2005-10-11 2007-04-26 Japan Health Science Foundation Cell removal processing of viable tissue for transplantation by supercritical carbon dioxide

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6719788B2 (en) * 1993-11-01 2004-04-13 3F Therapeutics, Inc. Replacement atrioventricular heart valve
US6126686A (en) * 1996-12-10 2000-10-03 Purdue Research Foundation Artificial vascular valves
US7331993B2 (en) * 2002-05-03 2008-02-19 The General Hospital Corporation Involuted endovascular valve and method of construction
US7887576B2 (en) * 2002-08-20 2011-02-15 Cook Incorporated Endoluminal device with extracellular matrix material and methods
US7087034B2 (en) * 2002-09-19 2006-08-08 Mcpherson William E Vascular shunt with audio flow indication
US6991649B2 (en) * 2003-08-29 2006-01-31 Hans-Hinrich Sievers Artificial heart valve
US20090157177A1 (en) * 2007-12-18 2009-06-18 Matheny Robert G Sewing Ring for a Prosthetic Tissue Valve

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8845719B2 (en) 2011-05-27 2014-09-30 Cormatrix Cardiovascular, Inc Extracellular matrix material conduits and methods of making and using same

Also Published As

Publication number Publication date
IL229287A0 (en) 2014-01-30
WO2012166554A2 (en) 2012-12-06
AU2012262554A8 (en) 2014-02-27
BR112013030482A2 (en) 2016-09-27
AU2012262554A1 (en) 2013-11-28
CA2835859A1 (en) 2012-12-06
AU2012262554B2 (en) 2016-09-15
KR20140145954A (en) 2014-12-24
JP2014519379A (en) 2014-08-14
WO2012166554A8 (en) 2014-01-23
SG194878A1 (en) 2013-12-30
IL229287B (en) 2019-05-30
JP2017060776A (en) 2017-03-30

Similar Documents

Publication Publication Date Title
HK1248092B (en) Truncated leaflet for prosthetic heart valves
ZA201501179B (en) Culture medium composition, and method for culturing cell or tissue using said composition
EP2639293A4 (en) Cell culture chamber, method for producing same, tissue model using cell culture chamber, and method for producing same
EP2670350A4 (en) Blunt ended stent for prosthetic heart vale
HUE059909T2 (en) Prosthetic heart valve improved commissure supports
EP2911708A4 (en) Novel nanofiber-based graft for heart valve replacement and methods of using the same
IL229284A0 (en) Sterilized, acellular extracellular matrix compositions and methods of making thereof
EP2677964A4 (en) Prosthetic heart valve delivery apparatus
EP2670351A4 (en) Leaflet suturing to commissure points for prosthetic heart valve
MX353579B (en) Liver organoid, uses thereof and culture method for obtaining them.
EP2671945A4 (en) Method for culturing human pluripotent stem cells
EP2588592A4 (en) Use of perfusion decellularized organs for matched recellularization
IL214486A (en) Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissue assemblies
EP3090704A4 (en) Method for preparing artificial heart valve leaflets
EP2774630A4 (en) Method for preparing edge-rigidized artificial biological valve
AU2013289661A8 (en) Decellularization method for preparing extracellular matrix support material
SG10201604332XA (en) Membrane and method for making the same
EP2639297A4 (en) Method for producing peripheral blood monocyte-derived pluripotent stem cells
EP2752192A4 (en) Method for preparing decellularized tissue product, and graft provided with decellularized tissue product
EP3395943A4 (en) Method for manufacturing tissue/organ by using blood cells
HK1210722A1 (en) Method for producing extended-release potassium citrate wax matrix tablet
PL2723850T3 (en) Method for cultivating cells in platelet-lysate-containing medium
EP2894143A4 (en) Method for producing optically active 2,3-dihydrofarnesal
WO2012166554A8 (en) Extracellular matrix material conduits and methods of making and using same
IL227544A0 (en) Lauflumide and the enantiomers thereof, method for preparing same and therapeutic uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12793466

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2835859

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2012793466

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2014512122

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 20137031538

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2012262554

Country of ref document: AU

Date of ref document: 20120524

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112013030482

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112013030482

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20131127